Ideas

Lifespan extension therapy:  Mangiferin, isolated from Mangifera Indica, increases life span via up-regulation of its target gene BubR1, 11/November/2017, 8.40 am

Lifespan extension therapy:  Mangiferin, isolated from Mangifera Indica, increases life span via up-regulation of its target gene BubR1, 11/November/2017, 8.40 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Ivermectin and Cantharidin inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 11/November/2017,  12.07 am

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Ivermectin and Cantharidin inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 11/November/2017,  12.07 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Natural product therapy for body weight control, energy homeostasis and TIIDM: Ampelopsin/Dihydromyricetin (DHM) increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 10/November/2017,11.59 pm

Natural product therapy for body weight control, energy homeostasis and TIIDM: Ampelopsin/Dihydromyricetin (DHM) increases REV-ERB and its down stream target genes, inhibits lipid accumulation, improves dyslipidemia and insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 10/November/2017,11.59 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, Florida 33458, USA shows that “Regulation of circadian behaviour and metabolism by synthetic…

read more

Molecular therapy for anxiety and depression: Rosiglitazone, an antidiapetic drug, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 11.49 pm

Molecular therapy for anxiety and depression: Rosiglitazone, an antidiapetic drug, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 10/November/2017, 11.49 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department of Stem Cell and…

read more

Molecular therapy for Cardiomyopathy: A pharmacological mixture encompassing Rivaroxaban (trade name: Xarelto) and Asprin decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 10/November/2017,  12.07 pm

Molecular therapy for Cardiomyopathy: A pharmacological mixture encompassing Rivaroxaban (trade name: Xarelto) and Asprin decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 10/November/2017,  12.07 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart function through microRNA-mediated Sox6 repression.” This…

read more

Lifespan extension therapy:  Formononetin, isolated from from Astragalus membranaceus (AM), increases life span via up-regulation of its target gene BubR1, 10/November/2017, 8.57 am

Lifespan extension therapy:  Formononetin, isolated from from Astragalus membranaceus (AM), increases life span via up-regulation of its target gene BubR1, 10/November/2017, 8.57 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more